Changsha Duxact Biotechnology Co., Ltd

  • Home

  • About Us

    • Company Profile

    • Company Culture

    • Expert Team

    • Development Path

    • Honor

  • Main Business

    • Digital-one-stop Clinical Research Service

    • IT-based Medical R&D construction

    • Precision Medicine

    • Project Dynamics

  • Platform Display

    • CENTEN

    • LINKMEDS

    • PHAMARK

    • TONOINFO

    • DUXACT MEDICAL LABORATORY

  • News

    • Duzheng News

  • Recruitment

    • Talent Concept

    • Contact Us

  • Duzheng Family

    • Happy Duzheng

Picture Name
Picture Name

中文

搜索历史清除全部记录
最多显示8条历史搜索记录噢~
All
  • All
  • Product Management
  • News
  • Introduction
Search
News

Duzheng News

  • Home page
Congratulations to Sanjin Group Hunan Sanjin Pharmaceutical Co., LTD. Lamotrigine tablets the second national review!

2021-12-14

Congratulations to Sanjin Group Hunan Sanjin Pharmaceutical Co., LTD. Lamotrigine tablets the second national review!


On November 26, 2021, irbesartan hydrochlorothiazide tablets of Beijing Sihuan Kebao Pharmaceutical Co., Ltd. were approved

2021-11-29

On November 26, 2021, irbesartan hydrochlorothiazide tablets of Beijing Sihuan Kebao Pharmaceutical Co., Ltd. were approved


Congratulations to Beijing Sihuan Kebao Pharmaceutical Co., Ltd. on the successful approval of irbesartan hydrochlorothiazide tablets!

2021-11-29

Congratulations to Beijing Sihuan Kebao Pharmaceutical Co., Ltd. on the successful approval of irbesartan hydrochlorothiazide tablets!


On November 19, 2021, faveravir tablets of Zhejiang Haizheng Pharmaceutical Co., Ltd. were approved

2021-11-22

On November 19, 2021, faveravir tablets of Zhejiang Haizheng Pharmaceutical Co., Ltd. were approved


Duxact news warmly congratulates Zhejiang Haizheng Pharmaceutical Co., Ltd. on the first approval of faveravir tablets in China!

2021-11-22

Duxact news warmly congratulates Zhejiang Haizheng Pharmaceutical Co., Ltd. on the first approval of faveravir tablets in China!


On November 12, 2021, Hunan Mingrui Pharmaceutical Co., LTD., Propofol Tenofovir fumarate tablets were approved

2021-11-17

On November 12, 2021, Hunan Mingrui Pharmaceutical Co., LTD., Propofol Tenofovir fumarate tablets were approved


Congratulations to Hunan Mingrui Pharmaceutical Co., LTD., for the successful approval of propofol fumarate tenofovir tablets!

2021-11-17

Congratulations to Hunan Mingrui Pharmaceutical Co., LTD., for the successful approval of propofol fumarate tenofovir tablets!


On January 1, 2021, tongnuo information released the internal test version of intelligent clinical research management platform (ICP)

2021-11-05

On January 1, 2021, tongnuo information released the internal test version of intelligent clinical research management platform (ICP)


< 1234...42 >
Changsha Duxact Biotechnology Co., Ltd

1

Service Hotline:
0731-85681666

Business License

Website construction:www.300.cn  Changsha seo tagThis site already supports IPV6